{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T23:00:30Z","timestamp":1773356430350,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11659-4","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:24:33Z","timestamp":1773318273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of genetic variation in TLR4 and TLR9 genes with susceptibility to invasive ductal breast carcinoma"],"prefix":"10.1007","volume":"53","author":[{"given":"Ayesha","family":"Khattak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Nauman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itrat","family":"Sabeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amjad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"11659_CR1","unstructured":"Fehri E, Ennaifer E, Ardhaoui M, Tounsi H, Rhouma RBH (2024) Boubaker. Thirty Years since the Discovery of Toll-Like Receptors. edited volume. Kumar, V: Intech open limited; United Kingdom. p 1-106"},{"issue":"3","key":"11659_CR2","doi-asserted-by":"publisher","first-page":"100937","DOI":"10.1016\/j.isci.2020.100937","volume":"23","author":"NR Chattopadhyay","year":"2020","unstructured":"Chattopadhyay NR, Chatterjee K, Tiwari N, Chakrabarti S, Sahu SK, Roy SD, Ghosh A, Reddy RR, Das P, Mal S, Karnar BB (2020) TLR9 polymorphisms might contribute to the ethnicity bias for EBV-infected Nasopharyngeal Carcinoma. Iscience 23(3):100937","journal-title":"Iscience"},{"issue":"19","key":"11659_CR3","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.3390\/cells11193137","volume":"11","author":"KD Kania","year":"2022","unstructured":"Kania KD, Har\u0119\u017ca D, Wilczy\u0144ski JR, Wilczy\u0144ski M, Jarych D, Malinowski A, Paradowska E (2022) The toll-like receptor 4 polymorphism Asp299Gly is associated with an increased risk of ovarian cancer. Cells 11(19):3137","journal-title":"Cells"},{"key":"11659_CR4","doi-asserted-by":"publisher","unstructured":"Arpac\u0131 E, Celik SK (2024) Can toll-like receptor 4 gene polymorphi\u0307sm play a role in pathogenesi\u0307s of breast cancer? https:\/\/doi.org\/10.21203\/rs.3.rs-5478033\/v1","DOI":"10.21203\/rs.3.rs-5478033\/v1"},{"key":"11659_CR5","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V (2025) Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med 31:1154\u20131162. https:\/\/doi.org\/10.1038\/s41591-025-03502-3","journal-title":"Nat Med"},{"key":"11659_CR6","doi-asserted-by":"publisher","first-page":"103851","DOI":"10.1016\/j.breast.2024.103851","volume":"79","author":"L Liao","year":"2025","unstructured":"Liao L (2025) Inequality in breast cancer: Global statistics from 2022 to 2050. Breast 79:103851","journal-title":"Breast"},{"key":"11659_CR7","unstructured":"National Breast Cancer Coalition (NBCC), Facts and Figs (2022) https:\/\/www.stopbreastcancer.org\/information-center\/facts-figures\/ (Accessed 21 Aug 2024)"},{"issue":"1","key":"11659_CR8","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1186\/s12889-019-7330-z","volume":"19","author":"S Zaheer","year":"2019","unstructured":"Zaheer S, Shah N, Maqbool SA, Soomro NM (2019) Estimates of past and future time trends in age-specific breast cancer incidence among women in Karachi, Pakistan: 2004\u20132025. BMC Public Health 19(1):1001","journal-title":"BMC Public Health"},{"issue":"3","key":"11659_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.33546\/bnj.2022","volume":"8","author":"R Bibi","year":"2022","unstructured":"Bibi R, Maneewat K, Sangchan H, Sae-sia W (2022) Persistent post-surgical pain and its relationship to health-related quality of life in Pakistani women after breast cancer surgery. Belitung Nurs J 8(3):258\u2013265","journal-title":"Belitung Nurs J"},{"key":"11659_CR10","unstructured":"Bangash NA (2023) Dawn E-Paper Pakistan. https:\/\/www.dawn.com\/news\/1782011 (Accessed on 21 Aug 2024)"},{"issue":"1","key":"11659_CR11","doi-asserted-by":"publisher","first-page":"26067","DOI":"10.1038\/s41598-025-09810-5","volume":"15","author":"W Elmetnawy","year":"2025","unstructured":"Elmetnawy W, Nader H, ElNahas T, Sabet S, Bassiony H, ElNahass Y (2025) Mutational spectrum of BRCA genes in Egyptian patients with breast cancer. Sci Rep 15(1):26067","journal-title":"Sci Rep"},{"issue":"1","key":"11659_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/genes16010082","volume":"16","author":"EDF Manna","year":"2025","unstructured":"Manna EDF, Serrano D, Cazzaniga L, Mannucci S, Zanzottera C, Fava F, Lazzeroni M (2025) Hereditary breast cancer: comprehensive risk assessment and prevention strategies. Genes 16(1):82","journal-title":"Genes"},{"issue":"5","key":"11659_CR13","first-page":"1308","volume":"14","author":"D Kumar","year":"2022","unstructured":"Kumar D, Tiwari N, Katoch N, Kakran N, Chatterjee A, Kumari N (2022) Breast cancer causes and symptoms-a review. INT-JECSE 14(5):1308\u20135581","journal-title":"INT-JECSE"},{"issue":"2","key":"11659_CR14","doi-asserted-by":"publisher","first-page":"641","DOI":"10.31557\/APJCP.2022.23.2.641","volume":"23","author":"M Mashaly","year":"2022","unstructured":"Mashaly M, Ghorab D, Hegazy M, Abdelkhalek M, Gaballa K, Elzehery R (2022) Association between Epstein-Barr virus gene polymorphism and breast cancer risk among Egyptian females. Asian Pac J Cancer Prev 23(2):641\u2013650","journal-title":"Asian Pac J Cancer Prev"},{"key":"11659_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1403764","volume":"15","author":"F Alhamdan","year":"2024","unstructured":"Alhamdan F, Bayarsaikhan G, Yuki K (2024) Toll-like receptors and integrins crosstalk. Front Immunol 15:1403764","journal-title":"Front Immunol"},{"issue":"66","key":"11659_CR16","doi-asserted-by":"publisher","first-page":"110635","DOI":"10.18632\/oncotarget.22372","volume":"8","author":"NA Deng","year":"2017","unstructured":"Deng NA, Zhou H, Fan H, Yuan Y (2017) Single nucleotide polymorphisms and cancer susceptibility. Oncotarget 8(66):110635","journal-title":"Oncotarget"},{"key":"11659_CR17","doi-asserted-by":"crossref","unstructured":"Hamta A, Komijani M, Hezaveh SK (2020) Prevalence of human herpes virus 8 infection and pattern of TLR4 rs4986791 polymorphism in women with breast cancer. Jentashapir J Cell Mol Biology 11(4): e109192","DOI":"10.5812\/jjcmb.109192"},{"issue":"4","key":"11659_CR18","first-page":"3868","volume":"13","author":"KS Allemailem","year":"2021","unstructured":"Allemailem KS, Almatroudi A, Alrumaihi F, Almansour NM, Aldakheel FM, Rather RA, Rah B (2021) Single nucleotide polymorphisms (SNPs) in prostate cancer: its implications in diagnostics and therapeutics. Am J translational Res 13(4):3868","journal-title":"Am J translational Res"},{"issue":"1","key":"11659_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-021-01678-x","volume":"18","author":"MM Gaglia","year":"2021","unstructured":"Gaglia MM (2021) Anti-viral and pro-inflammatory functions of Toll-like receptors during gamma-herpesvirus infections. Virol. J. 18(1):218","journal-title":"Virol. J."},{"issue":"1","key":"11659_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s43042-025-00706-7","volume":"26","author":"A Das","year":"2025","unstructured":"Das A, Banerjee A (2025) Genetic association of toll like receptors and breast cancer: a novel approach toward countering the breast cancer tumor invasiveness and recurrence. Egyptian Journal of Medical Human Genetics 26(1):71","journal-title":"Egyptian Journal of Medical Human Genetics"},{"issue":"2","key":"11659_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/1319-3767.153832","volume":"21","author":"S Liu","year":"2015","unstructured":"Liu S, Wang X, Shi Y, Han L, Zhao Z, Zhao C, Luo B (2015) Toll-like receptor gene polymorphisms and susceptibility to Epstein\u2013Barr virus-associated and-negative gastric carcinoma in Northern China. Saudi J Gastroenterol 21(2):95\u2013103","journal-title":"Saudi J Gastroenterol"},{"key":"11659_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1336696","volume":"14","author":"H Zheng","year":"2024","unstructured":"Zheng H, Wu X, Guo L, Liu J (2024) MyD88 signaling pathways: role in breast cancer. Front Oncol 14:1336696","journal-title":"Front Oncol"},{"issue":"4","key":"11659_CR23","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.breast.2012.04.001","volume":"21","author":"GE Theodoropoulos","year":"2012","unstructured":"Theodoropoulos GE, Saridakis V, Karantanos T, Michalopoulos NV, Zagouri F, Kontogianni P, Lymperi M, Gazouli M, Zografos GC (2012) Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development. Breast 21(4):534\u2013538","journal-title":"Breast"},{"key":"11659_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cancergen.2024.10.001","volume":"288","author":"EL de Moura","year":"2024","unstructured":"de Moura EL, Dos Santos IF, de Freitas PP, da Silva DM, Dos Santos ACM, e Silva ACP, de Souza Figueiredo EVM (2024) Influence of polymorphisms on the phenotype of TLR1, TLR4 and TLR9 genes and their association with cervical cancer: bioinformatics prediction analysis and a case-control study. Cancer Genet 288:59\u201367","journal-title":"Cancer Genet"},{"key":"11659_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082858","volume":"8","author":"L Zhu","year":"2013","unstructured":"Zhu L, Yuan H, Jiang T, Wang R, Ma H, Zhang S (2013) Association of TLR2 and TLR4 polymorphisms with risk of cancer: a meta-analysis. PLoS One 8:e82858","journal-title":"PLoS One"},{"key":"11659_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1479-5876-9-139","volume":"9","author":"C Bergmann","year":"2011","unstructured":"Bergmann C, Bachmann HS, Bankfalvi A, Lotfi R, P\u00fctter C, Wild CA et al (2011) Toll like receptor 4 single nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomas. Transl Med 9:139","journal-title":"Transl Med"},{"key":"11659_CR27","doi-asserted-by":"publisher","first-page":"1050e9","DOI":"10.1038\/nm1622","volume":"13","author":"L Apetoh","year":"2007","unstructured":"Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A et al (2007) Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13:1050e9","journal-title":"Nat Med"},{"issue":"3","key":"11659_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s12282-018-00935-2","volume":"26","author":"M Khademalhosseini","year":"2019","unstructured":"Khademalhosseini M, Arababadi MK (2019) Toll-like receptor 4 and breast cancer: an updated systematic review. Breast Cancer 26(3):265\u2013271","journal-title":"Breast Cancer"},{"issue":"6","key":"11659_CR29","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1089\/gtmb.2009.0045","volume":"13","author":"GE Etokebe","year":"2009","unstructured":"Etokebe GE, Kne\u017eevi\u0107 J, Petri\u010devi\u0107 B, Paveli\u0107 J, Vrbanec D, Dembi\u0107 Z (2009) Single-nucleotide polymorphisms in genes encoding toll-like receptor-2,-3,-4, and-9 in case\u2013control study with breast cancer. Genet Test Mol Biomarkers 13(6):729\u2013734","journal-title":"Genet Test Mol Biomarkers"},{"key":"11659_CR30","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/0300060513483398","volume":"41","author":"ZZ Lai","year":"2013","unstructured":"Lai ZZ, Ni-Zhang, Pan XL, Song L (2013) Toll-like receptor 9 (TLR9) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer. J Int Med Res 41:1027\u20131036","journal-title":"J Int Med Res"},{"key":"11659_CR31","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.4049\/jimmunol.178.5.3186","volume":"178","author":"UA Hasan","year":"2007","unstructured":"Hasan UA, Bates E, Takeshita F, Biliato A, Accardi R, Bouvard V, Mansour M, Vincent I, Gissmann L, Iftner T et al (2007) TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16. J Immunol 178:3186\u20133197","journal-title":"J Immunol"},{"issue":"8","key":"11659_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033040","volume":"102","author":"F Wang","year":"2023","unstructured":"Wang F, Wen X, Wen T, Liu Z (2023) Association of TLR4 gene 2026A\/G (rs1927914), 896A\/G (rs4986790), and 1196C\/T (rs4986791) polymorphisms and cancer susceptibility: meta-analysis and trial sequential analysis. Medicine (Baltimore) 102(8):e33040","journal-title":"Medicine (Baltimore)"},{"key":"11659_CR33","doi-asserted-by":"crossref","unstructured":"Semlali A, Jalouli M, Parine NR, Al Amri A, Arafah M, Al Naeem A, Alanazi MS (2017) Toll-like receptor 4 as a predictor of clinical outcomes of estrogen receptor-negative breast cancer in Saudi women. Onco Targets Ther 207\u20131216","DOI":"10.2147\/OTT.S112165"},{"key":"11659_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-13-219","volume":"13","author":"AJ Resler","year":"2013","unstructured":"Resler AJ, Malone KE, Johnson LG, Malkki M, Petersdorf EW, McKnight B, Madeleine MM (2013) Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study. BMC Cancer 13:1\u201310","journal-title":"BMC Cancer"},{"key":"11659_CR35","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1053\/j.gastro.2011.08.043","volume":"141","author":"A Eyking","year":"2011","unstructured":"Eyking A, Ey B, R\u00fcnzi M, Roig AI, Reis H, Schmid KW, Gerken G, Podolsky DK, Cario E (2011) Toll-like receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer. Gastroenterology 141:2154\u20132165","journal-title":"Gastroenterology"},{"key":"11659_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-665","volume":"10","author":"S Gonz\u00e1lez-Reyes","year":"2010","unstructured":"Gonz\u00e1lez-Reyes S, Mar\u00edn L, Gonz\u00e1lez L, Gonz\u00e1lez LO, Casar JM, Lamelas ML et al (2010) Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. BMC Cancer 10:665","journal-title":"BMC Cancer"},{"key":"11659_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-9966-29-92","volume":"29","author":"H Yang","year":"2010","unstructured":"Yang H, Zhou H, Feng P, Zhou X, Wen H, Xie X, Shen H, Zhu X (2010) Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion. J Exp Clin Cancer Res 29:1\u20138","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"11659_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46077-z","volume":"9","author":"NO Pandey","year":"2019","unstructured":"Pandey NO, Chauhan AV, Raithatha NS, Patel PK, Khandelwal R, Desai AN, Choxi Y, Kapadia RS, Jain ND (2019) Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility. Sci Rep 9(1):9729","journal-title":"Sci Rep"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11659-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11659-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11659-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:24:38Z","timestamp":1773318278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11659-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11659"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11659-4","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"29 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest, financial or otherwise, that could be perceived to influence the presented research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved from Research Ethics Board University of Peshawar, Pakistan (REB-04\/04).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Each human participant in this study was provided with writen consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"484"}}